Tumor immune surveillance defect of X-linked severe combined immunodeficiency is not Epstein-Barr virus specific

Pediatr Blood Cancer. 2008 Nov;51(5):706-9. doi: 10.1002/pbc.21651.

Abstract

Immunodeficient patients are at an increased risk of developing Epstein-Barr virus (EBV) associated lymphomas. We report a patient with X-linked severe combined immunodeficiency (X-SCID), who presented with an EBV-negative, B-cell non-Hodgkin lymphoma. The tumor did not resolve with chemotherapy or rituximab, but only after recovery of functional donor T-cells cell following hematopoietic stem cell transplantation (HSCT). This case illustrates that the cancer predilection associated with immunodeficient hosts may not be a specific immune defect in the recognition of viral specific antigens, and it could be a defect in immune surveillance necessary for elimination of cells with abnormalities in proliferation, function and/or apoptosis.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Bone Marrow Transplantation
  • Herpesvirus 4, Human / immunology*
  • Humans
  • Immunologic Surveillance*
  • Infant
  • Lymphoma, B-Cell / etiology*
  • Lymphoma, B-Cell / immunology
  • Lymphoma, B-Cell / therapy
  • Male
  • Severe Combined Immunodeficiency / complications*
  • Severe Combined Immunodeficiency / immunology*

Substances

  • Antineoplastic Agents